| Literature DB >> 3444799 |
R Wilson1, C G Semple, A M Reid, A C Glen, J H McKillop, J A Thomson.
Abstract
Serum thyrotrophin receptor antibody (TRAb) and thyroid stimulating hormone (TSH) (IRMA) levels were measured in 38 patients at one month after the end of a course of carbimazole/T3 therapy for Graves' disease. Despite the increased sensitivity of the IRMA assay a TSH measurement at this stage was found to be of no predictive value, in contrast to estimation of serum TRAb levels which correctly predicted relapse and remission in 90% of patients.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3444799 PMCID： PMC2428554 DOI： 10.1136/pgmj.63.743.755
Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401